Financhill
Back

Chugai Pharmaceutical Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Buy
60

CHGCY
Chugai Pharmaceutical

Last Price:
23.51
Seasonality Move:
6.78%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Chugai Pharmaceutical Price Quote

$23.51
-0.54 (-2.25%)
(Updated: November 12, 2024 at 3:40 PM ET)

Chugai Pharmaceutical Key Stats

Buy
60
Chugai Pharmaceutical (CHGCY) is a Buy

Day range:
$23.21 - $24.12
52-week range:
$14.52 - $26.00
Dividend yield:
1.14%
P/E ratio:
34.12
P/S ratio:
10.46
P/B ratio:
7.27%

Volume:
77.3K
Avg. volume:
229.3K
1-year change:
54.76%
Market cap:
$79.1B
Revenue:
$7.9B
EPS:
$0.78

How Much Does Chugai Pharmaceutical Make?

Is Chugai Pharmaceutical Growing As A Company?

  • What Is Chugai Pharmaceutical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.19%
  • What Is Chugai Pharmaceutical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.37%

Chugai Pharmaceutical Stock Price Performance

What Is Chugai Pharmaceutical 52-Week High & Low?

Chugai Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Chugai Pharmaceutical?

Is Chugai Pharmaceutical Cash Flow Positive?

  • What Is CHGCY Cash Flow From Operations?
    Cash flow from operations (TTM) is $2.9B
  • What Is Chugai Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$980M
  • What Is Chugai Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.4B

Chugai Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    CHGCY return on invested capital is 23.65%
  • What Is Chugai Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 20.1%
  • What Is CHGCY Return On Equity?
    ROE is a measure of profitability and is 21.98%

Chugai Pharmaceutical Earnings Date & Stock Price

Chugai Pharmaceutical Competitors

Chugai Pharmaceutical Dividend Yield

Chugai Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 37.25% 0%
Revenue: 19.04% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many CHGCY shares are owned by institutional investors?
    1.4M CHGCY shares are owned by institutional investors
  • How many CHGCY shares are owned by insiders?
    0 CHGCY shares are owned by insiders